Literature DB >> 35505207

Cell Type-Specific Signal Analysis in Epigenome-Wide Association Studies.

Charles E Breeze1,2.   

Abstract

Hundreds of epigenome-wide association studies (EWAS) have been performed, successfully identifying replicated epigenomic signals in processes such as aging and smoking. Despite this progress, it remains a major challenge in EWAS to detect both cell type-specific and cell type confounding effects impacting study results. One way to identify these effects is through eFORGE (experimentally derived Functional element Overlap analysis of ReGions from EWAS), a published tool that uses 815 datasets from large-scale mapping studies to detect enriched tissues, cell types, and genomic regions. Here, I show that eFORGE analysis can be extended to EWAS differentially variable positions (DVPs), identifying target cell types and tissues. In addition, I also show that eFORGE tissue-specific enrichment can be detected for sites below EWAS significance threshold. I develop on these and other analysis examples, extending our knowledge of eFORGE cell type- and tissue-specific enrichment results for different EWAS.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  DNA methylation; Differentially methylated position; Differentially variable position; Epigenome-wide association study

Mesh:

Year:  2022        PMID: 35505207     DOI: 10.1007/978-1-0716-1994-0_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Systematic localization of common disease-associated variation in regulatory DNA.

Authors:  Matthew T Maurano; Richard Humbert; Eric Rynes; Robert E Thurman; Eric Haugen; Hao Wang; Alex P Reynolds; Richard Sandstrom; Hongzhu Qu; Jennifer Brody; Anthony Shafer; Fidencio Neri; Kristen Lee; Tanya Kutyavin; Sandra Stehling-Sun; Audra K Johnson; Theresa K Canfield; Erika Giste; Morgan Diegel; Daniel Bates; R Scott Hansen; Shane Neph; Peter J Sabo; Shelly Heimfeld; Antony Raubitschek; Steven Ziegler; Chris Cotsapas; Nona Sotoodehnia; Ian Glass; Shamil R Sunyaev; Rajinder Kaul; John A Stamatoyannopoulos
Journal:  Science       Date:  2012-09-05       Impact factor: 47.728

2.  The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery.

Authors:  Hendrik G Stunnenberg; Martin Hirst
Journal:  Cell       Date:  2016-11-17       Impact factor: 41.582

3.  FTO Obesity Variant Circuitry and Adipocyte Browning in Humans.

Authors:  Melina Claussnitzer; Simon N Dankel; Kyoung-Han Kim; Gerald Quon; Wouter Meuleman; Christine Haugen; Viktoria Glunk; Isabel S Sousa; Jacqueline L Beaudry; Vijitha Puviindran; Nezar A Abdennur; Jannel Liu; Per-Arne Svensson; Yi-Hsiang Hsu; Daniel J Drucker; Gunnar Mellgren; Chi-Chung Hui; Hans Hauner; Manolis Kellis
Journal:  N Engl J Med       Date:  2015-08-19       Impact factor: 91.245

Review 4.  10 Years of GWAS Discovery: Biology, Function, and Translation.

Authors:  Peter M Visscher; Naomi R Wray; Qian Zhang; Pamela Sklar; Mark I McCarthy; Matthew A Brown; Jian Yang
Journal:  Am J Hum Genet       Date:  2017-07-06       Impact factor: 11.025

5.  eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data.

Authors:  Charles E Breeze; Dirk S Paul; Jenny van Dongen; Lee M Butcher; John C Ambrose; James E Barrett; Robert Lowe; Vardhman K Rakyan; Valentina Iotchkova; Mattia Frontini; Kate Downes; Willem H Ouwehand; Jonathan Laperle; Pierre-Étienne Jacques; Guillaume Bourque; Anke K Bergmann; Reiner Siebert; Edo Vellenga; Sadia Saeed; Filomena Matarese; Joost H A Martens; Hendrik G Stunnenberg; Andrew E Teschendorff; Javier Herrero; Ewan Birney; Ian Dunham; Stephan Beck
Journal:  Cell Rep       Date:  2016-11-15       Impact factor: 9.423

6.  An epigenetic signature in peripheral blood predicts active ovarian cancer.

Authors:  Andrew E Teschendorff; Usha Menon; Aleksandra Gentry-Maharaj; Susan J Ramus; Simon A Gayther; Sophia Apostolidou; Allison Jones; Matthias Lechner; Stephan Beck; Ian J Jacobs; Martin Widschwendter
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

7.  Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis.

Authors:  Yun Liu; Martin J Aryee; Leonid Padyukov; M Daniele Fallin; Espen Hesselberg; Arni Runarsson; Lovisa Reinius; Nathalie Acevedo; Margaret Taub; Marcus Ronninger; Klementy Shchetynsky; Annika Scheynius; Juha Kere; Lars Alfredsson; Lars Klareskog; Tomas J Ekström; Andrew P Feinberg
Journal:  Nat Biotechnol       Date:  2013-01-20       Impact factor: 54.908

8.  DNA methylation profiling of human chromosomes 6, 20 and 22.

Authors:  Florian Eckhardt; Joern Lewin; Rene Cortese; Vardhman K Rakyan; John Attwood; Matthias Burger; John Burton; Tony V Cox; Rob Davies; Thomas A Down; Carolina Haefliger; Roger Horton; Kevin Howe; David K Jackson; Jan Kunde; Christoph Koenig; Jennifer Liddle; David Niblett; Thomas Otto; Roger Pettett; Stefanie Seemann; Christian Thompson; Tony West; Jane Rogers; Alex Olek; Kurt Berlin; Stephan Beck
Journal:  Nat Genet       Date:  2006-10-29       Impact factor: 38.330

9.  Correcting for cell-type composition bias in epigenome-wide association studies.

Authors:  Robert Lowe; Vardhman K Rakyan
Journal:  Genome Med       Date:  2014-03-25       Impact factor: 11.117

10.  Smoking induces coordinated DNA methylation and gene expression changes in adipose tissue with consequences for metabolic health.

Authors:  Pei-Chien Tsai; Craig A Glastonbury; Melissa N Eliot; Sailalitha Bollepalli; Idil Yet; Juan E Castillo-Fernandez; Elena Carnero-Montoro; Thomas Hardiman; Tiphaine C Martin; Alice Vickers; Massimo Mangino; Kirsten Ward; Kirsi H Pietiläinen; Panos Deloukas; Tim D Spector; Ana Viñuela; Eric B Loucks; Miina Ollikainen; Karl T Kelsey; Kerrin S Small; Jordana T Bell
Journal:  Clin Epigenetics       Date:  2018-10-20       Impact factor: 6.551

View more
  1 in total

1.  Diversity in EWAS: current state, challenges, and solutions.

Authors:  Charles E Breeze; Jason Y Y Wong; Stephan Beck; Sonja I Berndt; Nora Franceschini
Journal:  Genome Med       Date:  2022-07-06       Impact factor: 15.266

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.